Herasight
Advanced Genetic Screening
Wilmington, United States · $3.0M raised
- Headquarters
- Wilmington, Delaware
- Employees
- 1–10
- Business Model
- B2C
- Website
- herasight.com
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedJan 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.
About
Herasight builds genetic tests for families, with research spanning monogenic conditions and complex disease prediction. The company offers embryo screening and validates polygenic scores using actual family data because screening must predict differences in disease risk within a family. Its approach combines ongoing scientific validation with genetic counseling to help parents interpret information in the context of their situations and values.
Summary
Herasight is a Biotech company based in Wilmington, United States. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Jan 2024. Investors include Lux Capital, Amplo and IA Ventures.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2024 (est.)
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/herasight"><img src="https://indexed.vc/api/badge/company/herasight" alt="Herasight on Indexed.vc" width="260" height="76" /></a>